NEURALTUS PHARMACEUTICALS, INC. — Form D
NEURALTUS PHARMACEUTICALS, INC. of SAN BRUNO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-04-07. The offering totals $18.0M, of which $4.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-04-07
- Form: D
- Accession: 0001104659-09-023029
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $18.0M
- Amount sold: $4.9M
- Remaining: $13.1M
- Minimum investment: $200
- Investors: 6
- Date of first sale: 2009-03-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-130017
Issuer
- Name: NEURALTUS PHARMACEUTICALS, INC.
- CIK: 0001459308
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2004
- Address: 1001 BAYHILL DRIVE, SAN BRUNO, CA, 94066
- Phone: (650) 424-1600
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Ari Azhir | Director | Boston, MA |
| James N Woody | Director | Palo Alto, CA |
| Ari Azhir | Executive Officer | Boston, MA |
| John Walker | Director | Birmingham, AL |
| James Woody | Director | Cardiff, CA |
| TERRY GOULD | Director | NESS ZIONA, L3 |
| Donald McGovern | Director | SAN BRUNO, CA |
| Annette Bianchi | Director | SAN BRUNO, CA |
| John Whelan | Executive Officer | SAN BRUNO, CA |
| Richard Casey | Director | SAN BRUNO, CA |
| Richard Casey | Executive Officer | SAN BRUNO, CA |
| Andrew Gengos | Director | Palo Alto, CA |
| Andrew Gengos | Executive Officer | Palo Alto, CA |
Other filings by this issuer (3)
More